Systematic Review of the Effect of Enteral Feeding on Gut Microbiota in Preterm Infants

JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing

Volumn 47, Issue 3, 2018, Pages 451-463

  Xu, Wanli ^a   Judge, Michelle P ^a   Maas, Kendra ^a   Hussain, Naveed ^a   McGrath, Jacqueline M ^a   Henderson, Wendy A ^a   Cong, Xiaomei ^a  

^a NONE

Author keywords

donor human milk; feeding; formula; long chain polyunsaturated fatty acids; microbiome; mother's own milk; prebiotics; probiotics; systematic review

Indexed keywords

PROBIOTIC AGENT;

BREAST MILK; DRUG EFFECT; ENTERIC FEEDING; GROWTH, DEVELOPMENT AND AGING; HUMAN; INFANT NUTRITION; INTESTINE FLORA; NEWBORN; PHYSIOLOGY; PREMATURITY; PROCEDURES;

ENTERAL NUTRITION; GASTROINTESTINAL MICROBIOME; HUMANS; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFANT, NEWBORN; INFANT, PREMATURE; MILK, HUMAN; PROBIOTICS;

EID: 85034452550     PISSN: 08842175     EISSN: 15526909     Source Type: Journal    
DOI: 10.1016/j.jogn.2017.08.009     Document Type: Article

References (84)

1. Aceti, A., Gori, D., Barone, G., Callegari, M.L., Fantini, M.P., Indrio, F., Corvaglia, L., Probiotics and time to achieve full enteral feeding in human milk-fed and formula-fed preterm infants: Systematic review and meta-analysis. Nutrients, 8(8), 2016, 471.
2. AlFaleh, K., Anabrees, J., Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database of Systematic Reviews, 2014(4), 2014, CD005496, 10.1002/14651858.CD005496.pub4.
3. Al-Hosni, M., Duenas, M., Hawk, M., Stewart, L.A., Borghese, R.A., Cahoon, M., Soll, R., Probiotics-supplemented feeding in extremely low-birth-weight infants. Journal of Perinatology 32:4 (2012), 253–259.
4. Armanian, A.M., Sadeghnia, A., Hoseinzadeh, M., Mirlohi, M., Feizi, A., Salehimehr, N., Shirani, Z., The effect of neutral oligosaccharides on fecal microbiota in premature infants fed exclusively with breast milk: A randomized clinical trial. Journal of Research in Pharmacy Practice 5:1 (2016), 27–34.
5. Arnold, J.W., Roach, J., Azcarate-Peril, M.A., Emerging technologies for gut microbiome research. Trends Microbiology 24:11 (2016), 887–901.
6. Balfegó, M., Canivell, S., Hanzu, F.A., Sala-Vila, A., Martinez-Medina, M., Murillo, S., Gomis, R., Effects of sardine-enriched diet on metabolic control, inflammation and gut microbiota in drug-naive patients with type 2 diabetes: A pilot randomized trial. Lipids in Health and Disease, 15(1), 2016, 78, 10.1186/s12944-016-0245-0.
7. Balshem, H., Helfand, M., Schunemann, H.J., Oxman, A.D., Kunz, R., Brozek, J., Guyatt, G.H., GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 64:4 (2011), 401–406.
8. Barrat, E., Michel, C., Poupeau, G., David-Sochard, A., Rival, M., Pagniez, A., Darmaun, D., Supplementation with galactooligosaccharides and inulin increases bacterial translocation in artificially reared newborn rats. Pediatric Research 64:1 (2008), 34–39.
9. Bier, D.M., German, J.B., Lönnerdal, B., Personalized nutrition for the diverse needs of infants and children. 2008, Karger, Basel, Switzerland.
10. Bode, L., Human milk oligosaccharides: Prebiotics and beyond. Nutrition Reviews 67:2 (2009), S183–S191.
11. Boehm, G., Lidestri, M., Casetta, P., Jelinek, J., Negretti, F., Stahl, B., Marini, A., Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants. Archives of Disease in Childhood-Fetal and Neonatal Edition 86:3 (2002), F178–F181.
12. Boleij, A., Tjalsma, H., Gut bacteria in health and disease: A survey on the interface between intestinal microbiology and colorectal cancer. Biological Reviews of the Cambridge Philosophical Society 87:3 (2012), 701–730.
13. Braga, T.D., da Silva, G.A., de Lira, P.I., de Carvalho Lima, M., Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: A double-blind, randomized, controlled trial. American Journal of Clinical Nutrition 93:1 (2011), 81–86.
14. Burcelin, R., Gut microbiota and immune crosstalk in metabolic disease. Molecular Metabolism 5:9 (2016), 771–781.
15. Campeotto, F., Suau, A., Kapel, N., Magne, F., Viallon, V., Ferraris, L., Butel, M.J., A fermented formula in pre-term infants: Clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory IgA. British Journal of Nutrition 105:12 (2011), 1843–1851, 10.1017/S0007114510005702.
16. Chaturvedi, P., Warren, C.D., Altaye, M., Morrow, A.L., Ruiz-Palacios, G., Pickering, L.K., Newburg, D.S., Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation. Glycobiology 11:5 (2001), 365–372.
17. Chrzanowska-Liszewska, D., Seliga-Siwecka, J., Kornacka, M.K., The effect of Lactobacillus rhamnosus GG supplemented enteral feeding on the microbiotic flora of preterm infants-double blinded randomized control trial. Early Human Development 88:1 (2012), 57–60.
18. Cong, X., Judge, M., Xu, W., Diallo, A., Janton, S., Brownell, E.A., Graf, J., Influence of feeding type on gut microbiome development in hospitalized preterm infants. Nursing Research 66:2 (2017), 123–133.
19. Cong, X., Xu, W., Romisher, R., Poveda, S., Forte, S., Starkweather, A., Henderson, W.A., Focus: Microbiome: Gut microbiome and infant health: Brain-gut-microbiota axis and host genetic factors. Yale Journal of Biology and Medicine 89:3 (2016), 299–308.
20. Dai, D., Walker, W.A., Protective nutrients and bacterial colonization in the immature human gut. Advances in Pediatrics 46 (1999), 353–382.
21. D'Argenio, V., Salvatore, F., The role of the gut microbiome in the healthy adult status. Clinica Chimica Acta 451 (2015), 97–102.
22. Deshpande, G., Rao, S., Patole, S., Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: A systematic review of randomised controlled trials. Lancet 369:9573 (2007), 1614–1620.
23. Deshpande, G., Rao, S., Patole, S., Bulsara, M., Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 125:5 (2010), 921–930.
24. Fernández-Carrocera, L.A., Solis-Herrera, A., Cabanillas-Ayón, M., Gallardo-Sarmiento, R.B., García-Pérez, C.S., Montaño-Rodríguez, R., Echániz-Aviles, M.O.L., Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis. Archives of Disease in Childhood-Fetal and Neonatal Edition 98:1 (2013), F5–F9.
25. German, J.B., Freeman, S.L., Lebrilla, C.B., Mills, D.A., Human milk oligosaccharides: Evolution, structures and bioselectivity as substrates for intestinal bacteria. Personalized Nutrition for the Diverse Needs of Infants and Children, Vol. 62, 2008, Karger, Basel, Switzerland, 205–222.
26. Ghosh, S., Molcan, E., DeCoffe, D., Dai, C., Gibson, D.L., Diets rich in n-6 PUFA induce intestinal microbial dysbiosis in aged mice. British Journal of Nutrition 110:3 (2013), 515–523.
27. Gibson, G.R., Probert, H.M., Van Loo, J., Rastall, R.A., Roberfroid, M.B., Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics. Nutrition Research Reviews 17:02 (2004), 259–275.
28. Gibson, G.R., Roberfroid, M.B., Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. The Journal of Nutrition 125:6 (1995), 1401–1402.
29. Gonia, S., Tuepker, M., Heisel, T., Autran, C., Bode, L., Gale, C.A., Human milk oligosaccharides inhibit candida albicans invasion of human premature intestinal epithelial cells. Journal of Nutrition 145:9 (2015), 1992–1998.
30. Gregory, K.E., Samuel, B.S., Houghteling, P., Shan, G., Ausubel, F.M., Sadreyev, R.I., Walker, W.A., Influence of maternal breast milk ingestion on acquisition of the intestinal microbiome in preterm infants. Microbiome, 4(1), 2016, 68, 10.1186/s40168-016-0214-x.
31. Groer, M.W., Luciano, A.A., Dishaw, L.J., Ashmeade, T.L., Miller, E., Gilbert, J.A., Development of the preterm infant gut microbiome: A research priority. Microbiome, 2, 2014, 38, 10.1186/2049-2618-2-38.
32. Guarner, F., Malagelada, J.R., Gut flora in health and disease. The Lancet 361:9356 (2003), 512–519.
33. Guthmann, F., Kluthe, C., Bührer, C., Probiotics for prevention of necrotising enterocolitis: An updated meta-analysis. Klinische Pädiatrie 222:5 (2010), 284–290.
34. Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Calder, P.C., Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology 11:8 (2014), 506–514.
35. Holscher, H.D., Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes 8:2 (2017), 172–184.
36. Huse, S.M., Ye, Y., Zhou, Y., Fodor, A.A., A core human microbiome as viewed through 16S rRNA sequence clusters. PLOS ONE, 7(6), 2012, e34242, 10.1371/journal.pone.0034242.
37. Janvier, A., Malo, J., Barrington, K.J., Cohort study of probiotics in a North American neonatal intensive care unit. The Journal of Pediatrics 164:5 (2014), 980–985.
38. Jiang, W., Wu, N., Wang, X., Chi, Y., Zhang, Y., Qiu, X., Liu, Y., Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Scientific Reports, 5, 2015, 8096, 10.1038/srep08096.
39. Kapiki, A., Costalos, C., Oikonomidou, C., Triantafyllidou, A., Loukatou, E., Pertrohilou, V., The effect of a fructo-oligosaccharide supplemented formula on gut flora of preterm infants. Early Human Development 83:5 (2007), 335–339.
40. Kianifar, H., Ahanchian, H., Grover, Z., Jafari, S., Noorbakhsh, Z., Khakshour, A., Kiani, M., Synbiotic in the management of infantile colic: A randomised controlled trial. Journal of Paediatrics and Child Health 50:10 (2014), 801–805.
41. La Rosa, P.S., Warner, B.B., Zhou, Y., Weinstock, G.M., Sodergren, E., Hall-Moore, C.M., Hoffmann, J.A., Patterned progression of bacterial populations in the premature infant gut. Proceedings of the National Academy of Sciences 111:34 (2014), 12522–12527.
42. Landers, S., Hartmann, B.T., Donor human milk banking and the emergence of milk sharing. Pediatric Clinics of North America 60:1 (2013), 247–260.
43. Li, Y., Shimizu, T., Hosaka, A., Kaneko, N., Ohtsuka, Y., Yamashiro, Y., Effects of Bifidobacterium breve supplementation on intestinal flora of low birth weight infants. Pediatrics International 46:5 (2004), 509–515.
44. Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gøtzsche, P.C., Ioannidis, J.P., Moher, D., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLOS Med, 6(7), 2009, e1000100, 10.1371/journal.pmed.1000100.
45. Loo, T.M., Kamachi, F., Watanabe, Y., Yoshimoto, S., Kanda, H., Arai, Y., Ozawa, T., Gut microbiota promotes obesity-associated liver cancer through PGE2-mediated suppression of antitumor immunity. Cancer Discovery 7:5 (2017), 522–538.
46. Lozupone, C.A., Knight, R., Species divergence and the measurement of microbial diversity. FEMS Microbiology Reviews 32:4 (2008), 557–578.
47. Luedtke, S.A., Yang, J.T., Wild, H.E., Probiotics and necrotizing enterocolitis: Finding the missing pieces of the probiotic puzzle. Journal of Pediatric Pharmacology and Therapeutics 17:4 (2012), 308–328.
48. Manzoni, P., Mostert, M., Leonessa, M.L., Priolo, C., Farina, D., Monetti, C., Gomirato, G., Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: A randomized study. Clinical Infectious Diseases 42:12 (2006), 1735–1742.
49. Marteau, P., Bacterial flora in inflammatory bowel disease. Digestive Diseases 27:Suppl 1 (2009), 99–103.
50. Menni, C., Jackson, M.A., Pallister, T., Steves, C.J., Spector, T.D., Valdes, A.M., Gut microbiome diversity and high-fibre intake are related to lower long-term weight gain. International Journal of Obesity 41:7 (2017), 1099–1105.
51. Mihatsch, W.A., Braegger, C.P., Decsi, T., Kolacek, S., Lanzinger, H., Mayer, B., Stadtmüller, U., Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants. Clinical Nutrition 31:1 (2012), 6–15.
52. Mohan, R., Koebnick, C., Schildt, J., Schmidt, S., Mueller, M., Possner, M., Blaut, M., Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: A double-blind, placebo-controlled, randomized study. Journal of Clinical Microbiology 44:11 (2006), 4025–4031.
53. Moles, L., Escribano, E., de Andrés, J., Montes, M.T., Rodríguez, J.M., Jiménez, E., Espinosa-Martos, I., Administration of Bifidobacterium breve PS12929 and Lactobacillus salivarius PS12934, two strains isolated from human milk, to very low and extremely low birth weight preterm infants: A pilot study. Journal of Immunology Research, 2015, 2015, 538171, 10.1155/2015/538171.
54. Morgan, X.C., Huttenhower, C., Human microbiome analysis. PLOS Computational Biology, 8(12), 2012, e1002808, 10.1371/journal.pcbi.1002808.
55. Neu, J., Preterm infant nutrition, gut bacteria, and necrotizing enterocolitis. Current Opinion in Clinical Nutrition and Metabolic Care 18:3 (2015), 285–288, 10.1097/MCO.0000000000000169.
56. Newburg, D.S., Ruiz-Palacios, G.M., Morrow, A.L., Human milk glycans protect infants against enteric pathogens. Annual Review of Nutrition 25 (2005), 37–58.
57. Ninonuevo, M.R., Bode, L., Infant formula oligosaccharides opening the gates (for speculation): Commentary on the article by Barrat et al. on page 34. Pediatric Research 64:1 (2008), 8–10, 10.1203/PDR.0b013e3181752c2f.
58. Ninonuevo, M.R., Park, Y., Yin, H., Zhang, J., Ward, R.E., Clowers, B.H., Lebrilla, C.B., A strategy for annotating the human milk glycome. Journal of Agricultural and Food Chemistry 54:20 (2006), 7471–7480.
59. Noriega, B.S., Sanchez-Gonzalez, M.A., Salyakina, D., Coffman, J., Understanding the impact of omega-3 rich diet on the gut microbiota. Case Reports in Medicine, 2016, 2016, 3089303, 10.1155/2016/3089303.
60. Patel, K., Konduru, K., Patra, A.K., Chandel, D.S., Panigrahi, P., Trends and determinants of gastric bacterial colonization of preterm neonates in a NICU setting. PLOS ONE, 10(7), 2015, e0114664, 10.1371/journal.pone.0114664.
61. Pu, S., Khazanehei, H., Jones, P.J., Khafipour, E., Interactions between obesity status and dietary intake of monounsaturated and polyunsaturated oils on human gut microbiome profiles in the Canola Oil Multicenter Intervention Trial (COMIT). Frontiers in Microbiology, 7, 2016, 1612, 10.3389/fmicb.2016.01612.
62. Quigley, E.M., Gut bacteria in health and disease. Gastroenterology & Hepatology 9:9 (2013), 560–569.
63. Reeves, A.A., Johnson, M.C., Vasquez, M.M., Maheshwari, A., Blanco, C.L., TGF-β2, a protective intestinal cytokine, is abundant in maternal human milk and human-derived fortifiers but not in donor human milk. Breastfeeding Medicine 8:6 (2013), 496–502.
64. Reid, G., Younes, J.A., Van der Mei, H.C., Gloor, G.B., Knight, R., Busscher, H.J., Microbiota restoration: Natural and supplemented recovery of human microbial communities. Nature Reviews Microbiology 9:1 (2011), 27–38.
65. Robinson, D.T., Caplan, M.S., Linking fat intake, the intestinal microbiome, and necrotizing enterocolitis in premature infants. Pediatric Research 77:1–2 (2015), 121–126.
66. Romeo, M.G., Romeo, D.M., Trovato, L., Oliveri, S., Palermo, F., Cota, F., Betta, P., Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: Incidence of late-onset sepsis and neurological outcome. Journal of Perinatology 31:1 (2011), 63–69.
67. Rougé, C., Piloquet, H., Butel, M.J., Berger, B., Rochat, F., Ferraris, L., Vodovar, M., Oral supplementation with probiotics in very-low-birth-weight preterm infants: A randomized, double-blind, placebo-controlled trial. American Journal of Clinical Nutrition 89:6 (2009), 1828–1835.
68. Round, J.L., Mazmanian, S.K., The gut microbiota shapes intestinal immune responses during health and disease. Nature Reviews Immunology 9:5 (2009), 313–323.
69. Rozanova, G.N., Voevodin, D.A., Stenina, M.A., Kushnareva, M.V., Pathogenetic role of dysbacteriosis in the development of complications of type 1 diabetes mellitus in children. Bulletin of Experimental Biology and Medicine 133:2 (2002), 164–166.
70. Rudloff, S., Kunz, C., Milk oligosaccharides and metabolism in infants. Advances in Nutrition: An International Review Journal 3:3 (2012), 398S–405S.
71. Ruiz-Palacios, G.M., Cervantes, L.E., Ramos, P., Chavez-Munguia, B., Newburg, D.S., Campylobacter jejuni binds intestinal H (O) antigen (Fucα1, 2Galβ1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. Journal of Biological Chemistry 278:16 (2003), 14112–14120.
72. Srinivasjois, R., Rao, S., Patole, S., Prebiotic supplementation in preterm neonates: Updated systematic review and meta-analysis of randomised controlled trials. Clinical Nutrition 32:6 (2013), 958–965.
73. Thomas, H., Paediatrics: Gut microbiota dysbiosis precedes NEC. Nature Reviews Gastroenterology & Hepatology, 13(5), 2016, 252.
74. Turnbaugh, P.J., Hamady, M., Yatsunenko, T., Cantarel, B.L., Duncan, A., Ley, R.E., Gordon, J.I., A core gut microbiome in obese and lean twins. Nature, 457(7228), 2009.
75. Underwood, M.A., Kalanetra, K.M., Bokulich, N.A., Lewis, Z.T., Mirmiran, M., Tancredi, D.J., Mills, D.A., A comparison of two probiotic strains of bifidobacteria in premature infants. Journal of Pediatrics 163:6 (2013), 1585–1591.
76. Underwood, M.A., Kalanetra, K.M., Bokulich, N.A., Mirmiran, M., Barile, D., Tancredi, D.J., Mills, D.A., Prebiotic oligosaccharides in premature infants. Journal of Pediatric Gastroenterology and Nutrition 58:3 (2014), 352–360.
77. Wang, Q., Dong, J., Zhu, Y., Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: An updated meta-analysis of 20 randomized, controlled trials. Journal of Pediatric Surgery 47:1 (2012), 241–248.
78. Warner, B.B., Deych, E., Zhou, Y., Hall-Moore, C., Weinstock, G.M., Sodergren, E., Khanna, G., Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: A prospective case-control study. The Lancet 387:10031 (2016), 1928–1936.
79. Westerbeek, E.A.M., Slump, R.A., Lafeber, H.N., Knol, J., Georgi, G., Fetter, W.P.F., van Elburg, R.M., The effect of enteral supplementation of specific neutral and acidic oligosaccharides on the faecal microbiota and intestinal microenvironment in preterm infants. European Journal of Clinical Microbiology & Infectious Diseases 32:2 (2013), 269–276.
80. Whelan, K., Enteral-tube-feeding diarrhoea: Manipulating the colonic microbiota with probiotics and prebiotics. Proceedings of the Nutrition Society 66:3 (2007), 299–306, 10.1017/S0029665107005551.
81. Whelan, K., Gibson, G.R., Judd, P.A., Taylor, M.A., The role of probiotics and prebiotics in the management of diarrhoea associated with enteral tube feeding. Journal of Human Nutrition and Dietetics 14:6 (2001), 423–433.
82. Yamamoto, M., Matsumoto, S., Gut microbiota and colorectal cancer. Genes and Environment, 38(1), 2016, 11, 10.1186/s41021-016-0038-8.
83. Yu, H.N., Zhu, J., Pan, W.S., Shen, S.R., Shan, W.G., Das, U.N., Effects of fish oil with a high content of n-3 polyunsaturated fatty acids on mouse gut microbiota. Archives of Medical Research 45:3 (2014), 195–202.
84. Zhu, Q., Gao, R., Wu, W., Qin, H., The role of gut microbiota in the pathogenesis of colorectal cancer. Tumor Biology 34:3 (2013), 1285–1300.